Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04573153 |
|
Recruitment Status : Unknown
Verified September 2020 by ScandiBio Therapeutics AB.
Recruitment status was: Recruiting
First Posted : October 5, 2020
Last Update Posted : October 6, 2020
|
Sponsor:
ScandiBio Therapeutics AB
Collaborators:
Istanbul Medipol University Hospital
Istanbul Umraniye Training and Research Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Bagcilar Training and Research Hospital
Kanuni Sultan Suleyman Training and Research Hospital
Alanya Alaaddin Keykubat University Alanya Training and Research Hospital
Canakkale 18 Mart University Health Research and Application Hospital
Monitor CRO
Information provided by (Responsible Party):
ScandiBio Therapeutics AB
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | January 31, 2021 |
| Estimated Study Completion Date : | March 31, 2021 |